Biocon Biologics
Mandar Ghatnekar is the Global Head of IT & Digital Transformation at Biocon Biologics. Prior to that, Mandar worked as a Managing Director at Accenture and held various roles at companies like Johnson & Johnson, Infosys Technologies Limited, Mascon Global, and Biotechnology Resource Center Ltd. Mandar has a strong background in IT, digital transformation, and life sciences, with a focus on systems integration, application outsourcing, and bioprocess technology. Mandar holds a M.Sc. (Tech) and Ph.D. (Tech) in Bioprocess Technology from the University of Mumbai, as well as a B.Pharm in Pharmaceutical Sciences from Savitribai Phule Pune University and University of Pune.
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics